Results 211 to 220 of about 48,420 (304)

Budesonide and Surfactant Therapy Versus Surfactant Alone on Incidence of Lung Disease in Preterm Infants (BEST Lung): Study Protocol for a Systematic Review and Individual Participant Data Meta‐Analysis With Nested Prospective Meta‐Analysis

Acta Paediatrica, EarlyView.
ABSTRACT Introduction Bronchopulmonary dysplasia (BPD) is a leading cause of morbidity and mortality in preterm infants. Combining surfactant with budesonide has been proposed to prevent BPD, but results from existing randomised controlled trials (RCTs) are conflicting.
James X. Sotiropoulos, Brett J. Manley, Sol Libesman, Namasivayam Ambalavanan, Abhik Das, Christopher J. D. Mckinlay, Nalinikanta Panigrahy, Melinda Cruz, David Nguyen, Jonathan Williams, Peter Davis, Kylie E. Hunter, Anna Lene Seidler   +12 more
wiley   +1 more source

[Therapy of respiratory insufficiency. Oxygen inhalation therapy, including home oxygen therapy].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999
openaire   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

British Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

[Oxygen inhalation therapy of respiratory failure].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992
openaire   +1 more source

Anesthetic Strategy for 30 Radiotherapy Sessions in a Child With Autism Spectrum Disorder (ASD) and Severe Behavioral Dysregulation: A Case Report. [PDF]

Cureus
Imbelloni L, Rivoli A, Lemos Neto SV, Santos MV, SantaRosa AA, Modolo NP.   +5 more
europepmc   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

[Respiratory failure and oxygen inhalation therapy].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990
openaire   +1 more source

Biological Safety Analysis of Nanoparticles: Exploring Toxicity, Mechanisms, and Safety Factors for Pharmaceuticals. [PDF]

Int J Nanomedicine
Huang A, Jiang Z, Liang Z, Tang N, Liu J, Yu XA, Wang B, Wang X.   +7 more
europepmc   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source

Severe chest and back pain due to extra-pulmonary emphysema above 5,000 m: a series of case reports. [PDF]

Front Med (Lausanne)
Gan Z, Wu J, Tian J, Han X, Yang Q, Zhang L, Yang X, Han X.   +7 more
europepmc   +1 more source